Your Location:
Home >
Browse articles >
Clinical Efficacy of Modified Qingqi Huatan Wan in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Syndrome of Phlegm-heat Obstructing Lung and Effect on Serum TNF-α, IL-8 and MMP-9
Classic Prescriptions | Updated:2021-02-09
    • Clinical Efficacy of Modified Qingqi Huatan Wan in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Syndrome of Phlegm-heat Obstructing Lung and Effect on Serum TNF-α, IL-8 and MMP-9

    • LIU Rui , HOU Ti-bao , HE Jia , YE Chuan-dong
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 9, Pages: 31-37(2019)
    • DOI: 10.13422/j.cnki.syfjx.20182212     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Figs( 0 ) Tabs( 5 )

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

108

Views

77

Downloads

3

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Clinical Efficacy of Modified Qingqi Huatan Wan in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Inflammatory Reaction, Airway Remodeling and Thrombokinesis
Clinical Observation on Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (Syndrome of Phlegm-heat Obstructing Lung) with Qingke Pingchuan Granules
Effect of Qingjin Huatantang on AECOPD Inflammatory Factors by Regulating p62
Molecular Mechanisms and Research Progress of Traditional Chinese Medicine Intervention in Diabetic Foot Ulcers Based on Regulation of Inflammation-oxidative Stress Axis
Tongnao Decoction Promotes Angiogenesis and Alleviates Cerebral Ischemic Injury via PI3K/Akt/GSK-3β Signaling Pathway

Related Author

ZHANG Zhijie
CUI Hongsheng
HUANG Guirui
ZHANG Shiyu
WANG Yanyan
LI Jiaqi
Mei ZHAO
Jin PAN

Related Institution

The Third Affiliated Hospital of Beijing University of Chinese Medicine
Beijing University of Chinese Medicine
Guangxi University of Chinese Medicine
The First Affiliated Hospital of Guangxi University of Chinese Medicine
The First Clinical College of Anhui University of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine